Fingerprint
Dive into the research topics of 'An evidence-based review of natalizumab therapy in the management of Crohn's disease'. Together they form a unique fingerprint.
Medicine & Life Sciences
Natalizumab
Crohn Disease
Integrin alpha Chains
Cell Migration Inhibition
Tumor Necrosis Factor-alpha
Progressive Multifocal Leukoencephalopathy
Remission Induction
Biological Therapy
Biological Factors
Therapeutics
Endothelium
Immunosuppressive Agents
Safety
Antibodies
Chemical Compounds
Natalizumab
Refractory materials
Tumor Necrosis Factor-alpha
Biological Factors
Molecules
Cells
Integrins
Adhesion
Immunosuppressive Agents
Antibodies
Engineering & Materials Science
Tumor Necrosis Factor-alpha
Refractory materials
Antibodies
Molecules
Cells
Adhesion
Social Sciences
management
evidence
induction
indication
migration
history